hydroxyindoleacetic acid has been researched along with Multiple System Atrophy Syndrome in 3 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kaiserova, M | 1 |
| Chudackova, M | 1 |
| Prikrylova Vranova, H | 1 |
| Mensikova, K | 1 |
| Kastelikova, A | 1 |
| Stejskal, D | 1 |
| Kanovsky, P | 1 |
| Abdo, WF | 2 |
| De Jong, D | 1 |
| Hendriks, JC | 1 |
| Horstink, MW | 1 |
| Kremer, BP | 1 |
| Bloem, BR | 2 |
| Verbeek, MM | 2 |
| van de Warrenburg, BP | 1 |
| Munneke, M | 1 |
| van Geel, WJ | 1 |
| Kremer, HP | 1 |
3 other studies available for hydroxyindoleacetic acid and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson's Disease and Atypical Parkinsonian Syndromes.
Topics: Diagnosis, Differential; Humans; Hydroxyindoleacetic Acid; Multiple System Atrophy; Parkinson Diseas | 2021 |
Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease.
Topics: Adult; Aged; Benzamides; Brain; Diagnosis, Differential; Electromyography; Enzyme-Linked Immunosorbe | 2004 |
CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia.
Topics: Age of Onset; Biomarkers; Cerebellar Ataxia; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mi | 2006 |